DNA

ALIGNMT AI Collaborates with Leading Global Cancer Center to Advance AI Governance in Healthcare

ALIGNMT joins the MSK Innovation Hub to Collaboratively Pilot its AI Governance Platform for Operationalizing MSK's AI Lifecycle Management Framework…

3 months ago

Cancer AI Alliance Unveils First Collaborative AI Platform for Cancer Research

Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments SEATTLE, WASHINGTON / ACCESS Newswire /…

3 months ago

Navinci Launches Naveni® Plex Omni Service Providing Expert-Led Access to Spatial Interactomics

UPPSALA, Sweden, Sept. 30, 2025 /PRNewswire/ -- Navinci today announced the launch of the Naveni® Plex Omni Service, a new offering…

3 months ago

Epigenica AB Launches the Groundbreaking EpiFinder™ GenomePro – Unlocking the Epigenome with Unprecedented High Throughput and Multiplexing Features

SOLNA, Sweden, Sept. 30, 2025 /PRNewswire/ -- Epigenica AB, the leader in epigenomic innovation, proudly announces the launch of the…

3 months ago

SumHealth and Nucleus Genomics Partner to Bring Whole-Genome DNA Testing Into Healthcare Infrastructure

Partnership Makes Advanced, Clinical-Grade Genetic Insights Affordable and Accessible Through Hospitals, Pharmacies and Healthcare Systems Nationwide CHARLOTTE, NORTH CAROLINA /…

3 months ago

SumHealth and Nucleus Genomics Partner to Bring Whole-Genome DNA Testing Into Healthcare Infrastructure

Partnership Makes Advanced, Clinical-Grade Genetic Insights Affordable and Accessible Through Hospitals, Pharmacies and Healthcare Systems Nationwide CHARLOTTE, NORTH CAROLINA /…

3 months ago

Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

- Keynote: “IM8: The World’s Fastest-Growing Supplement Brand Powering Our Bitcoin Treasury - Prenetics currently holds 246 BTC with a…

3 months ago

LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025

Additional time enables LAVA Therapeutics to address potential liabilities and confirm net cash to be delivered to Shareholders. LAVA Therapeutics…

3 months ago

Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes

ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on…

3 months ago

Embleema Awarded $5M Department of Defense Contract. Partners With GRAVL and Aria Diagnostics to Create Global Pathogen Bio Surveillance Infrastructure

BOSTON, Sept. 29, 2025 /PRNewswire/ -- Embleema, in partnership with GRAVL and Aria Diagnostics (ARIA), has secured a $5 million…

3 months ago